No professional sees more young children, more regularly, than the pediatrician. Well-child visits put pediatric clinicians in front of children at exactly the ages when the earliest signs of autism emerge — which makes primary care the front line of early identification, whether or not it ever makes the diagnosis itself.
This article walks through the pediatrician’s role as it actually works: surveillance, screening, the referral decision, and the conversation with families in between.
Surveillance: The Everyday Work of Watching Development
The American Academy of Pediatrics recommends developmental surveillance at every well-child visit — the ongoing, informal process of eliciting parent concerns, observing the child, and tracking milestones over time (AAFP summary of AAP guidance).
Surveillance is where most early concerns first surface, and parent concerns deserve particular weight. When a parent says “he doesn’t respond to his name” or “she doesn’t look at me the way her sister did,” that observation is clinically meaningful — parents observe their child across hundreds of hours that no clinician will ever see.
Screening: The Structured Checkpoints
Layered on top of surveillance, the AAP recommends:
- General developmental screening with a validated instrument at the 9-, 18-, and 30-month visits
- Autism-specific screening for all children at the 18- and 24-month visits, commonly with the M-CHAT-R/F (AAP; HealthyChildren.org)
Two points are worth underscoring. First, screening is universal — it applies to every child, not only those with visible concerns, because screening exists precisely to catch what surveillance misses. Second, a screener is not a diagnosis. A positive M-CHAT result identifies elevated likelihood and triggers next steps; it doesn’t answer the diagnostic question. (We cover this distinction in screeners vs. diagnostic tools.)
The Referral Decision — and the Trap of Watchful Waiting
When screening or surveillance raises concern, guidance is consistent: refer promptly — for comprehensive diagnostic evaluation, for early intervention eligibility, and for audiology to rule out hearing loss. Notably, these referrals can proceed in parallel; early intervention does not need to wait for a completed diagnosis.
The pattern to avoid is prolonged reassurance — “let’s see where things are in six months.” It’s an understandable instinct, especially with mild or ambiguous presentations. But with diagnostic waitlists often running months, a six-month watchful wait plus a long queue can add up to a year of lost time at ages when early support can matter most. Early diagnosis matters because it opens the door to earlier support — the case we lay out in why early autism diagnosis matters.
The practical stance many developmental specialists recommend: refer on concern, not on certainty. Certainty is the evaluation’s job.
The Conversation With Families
How a concern is raised shapes everything that follows. A few principles that serve pediatric clinicians well:
- Lead with the specific observation, not the label. “I noticed she isn’t yet responding to her name, and I take that seriously” lands better than opening with “autism.”
- Treat the parent as the expert observer. Ask what they’ve noticed. Their answers usually enrich the clinical picture.
- Frame referral as information-gathering. An evaluation is how the family gets answers — not a verdict.
- Name a concrete next step. Families cope better with a plan: who to call, what to expect, roughly how long it takes.
Where Newer Tools Fit
One persistent frustration for pediatricians is what happens after referral: the long gap between a positive screen and diagnostic answers. Part of the response across the field has been expanding diagnostic capacity — including technologies that support qualified clinicians in the evaluation itself.
The EarliPoint System is an FDA-cleared medical device indicated for use as a tool to aid qualified clinicians in the diagnosis and assessment of ASD in children 16 to 95 months old who are at risk based on concerns shared by a parent, caregiver, or healthcare provider. The child watches short socially rich videos while eye-tracking measures looking behavior; the resulting data supports — and never replaces — the qualified clinician’s judgment. Its diagnostic accuracy studies were published in JAMA (EarliPoint Health Research). For referring pediatricians, there is a growing number of communities that offer evaluations supported by objective measurement, searchable through the EarliPoint network page.
Frequently Asked Questions
At what ages does the AAP recommend autism screening?
Autism-specific screening for all children at the 18- and 24-month well-child visits, in addition to general developmental screening at 9, 18, and 30 months and surveillance at every visit.
Should a pediatrician wait for a positive screen to refer?
No. Screening supplements clinical judgment — it doesn’t cap it. Significant parent or clinician concern warrants referral even with a negative screen, and guidance supports referring for evaluation, early intervention, and audiology in parallel.
Can pediatricians diagnose autism?
Diagnosis is made by qualified clinicians through comprehensive evaluation — most often developmental-behavioral pediatricians, child psychologists, neuropsychologists, psychiatrists, or neurologists. A growing number of primary care pediatricians with additional training take on diagnostic evaluation, particularly in access-limited regions.
What should a family be told after a positive screen?
A screen identifies the need for a closer look but does not in an of itself qualify as a diagnosis — and that the next steps are a comprehensive evaluation, an early intervention referral, and a hearing check, which can all proceed at the same time.
